After Wegovy recommended by Britain's drug price regulator, Novo Nordisk shares rise
Corroborated by 2 sources from 2 publishers
ukhealth5h ago
TL;DR
Reports differ across sources; according to forbes.com, topline Key Facts Novo Nordisk stock was up about 1.5% in premarket on the news.
Sources
1
Forbes Business
https://www.forbes.com/sites/maryroeloffs/2026/03/31/wegovy-subscription-launched-will-save-users-up-to-1200-per-year-novo-nordisk-says
1d ago
2
CNBC 10000108
https://www.cnbc.com/2026/03/31/novo-nordisk-wegovy-subscription-glp-1-obesity-drugs.html
20h ago
3
CNBC Top News
https://www.cnbc.com/2026/04/01/novo-nordisk-stock-wegovy-ozempic-nice-nhs-nvo.html
3h ago